PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsEndometriosis
MeSH D004715 - endometriosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005831:Female genital diseases
$
Success rate
D004715: 
Endometriosis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieLeuprolide, Norethindrone Lupaneta Pack  2012-12-14   
Leuprolide Lupron  1985-04-09 $783 M Y2021 
Leuprolide Lupron Depot  1989-01-26   
Leuprolide Lupron Depot-ped 2028-03-22 1993-04-16   
Elagolix Oriahnn 2024-09-10 2020-05-29 $145 M Y2021 
Accord HealthcareLeuprolide Camcevi 2027-01-16 2021-05-25   
AllerganEthinyl estradiol, Norethindrone Brevicon  1982-01-01   
Ethinyl estradiol, Norethindrone Estrostep Fe  1996-10-09   
Ethinyl estradiol, Norethindrone Femcon Fe  2003-11-14   
Ethinyl estradiol, Norethindrone Femhrt  1999-10-15   
Ethinyl estradiol, Norethindrone Lo Loestrin Fe 2029-02-02 2010-10-21   
Ethinyl estradiol, Norethindrone Lo Minastrin Fe 2029-02-02 2013-07-24   
Ethinyl estradiol, Norethindrone Minastrin  2013-05-08   
Ethinyl estradiol, Norethindrone Norinyl 1+35  1982-01-01   
Ethinyl estradiol, Norethindrone Taytulla  2013-04-19   
Ethinyl estradiol, Desogestrel Desogestrel Ethinyl Estradiol  2005-07-29   
Ethinyl estradiol, Norethindrone Norethin  1988-04-12   
Ethinyl estradiol, Norethindrone Norethindrone Ethinyl Estradiol  1987-01-29   
Ethinyl estradiol, Norethindrone Norethindrone Ethinyl Estradiol ()  1991-09-24   
Norethindrone, Mestranol Norethindrone Mestranol  1988-07-01   
Norethindrone, Mestranol Norinyl  1982-01-01   
Norethindrone, Mestranol Norinyl 1+50  1982-01-01   
American TherapeuticsDanazol Danazol  1987-12-30   
Amneal PharmaceuticalsEstradiol, Norethindrone Activella  1998-11-18   
Leuprolide Leuprolide  2022-10-28   
Norethindrone Norethindrone  2012-07-30   
Ethinyl estradiol, Norethindrone Norethindrone Ethinyl Estradiol Ferrous  2009-09-01   
Annora PharmaEthinyl estradiol, Desogestrel Desogestrel Ethinyl Estradiol  2026-03-18   
ApotexEthinyl estradiol, Norethindrone Norethindrone Ethinyl Estradiol Ferrous  2018-03-21   
Aspen GlobalEthinyl estradiol, Desogestrel Cyclessa  2000-12-20   
Aurobindo PharmaEthinyl estradiol, Norethindrone Aurovela  2017-06-15   
Ethinyl estradiol, Norethindrone Cyonanz  2016-10-21   
Norethindrone Incassia  2016-09-23   
Ethinyl estradiol, Desogestrel Kalliga  2017-05-17   
Ethinyl estradiol, Norethindrone Nexesta Fe  2017-02-02   
Norethindrone Norethindrone  2016-01-08   
Ethinyl estradiol, Norethindrone Nylia  2016-10-21   
Ethinyl estradiol, Norethindrone Rhuzdah  2022-10-11   
Ethinyl estradiol, Desogestrel Simliya  2017-03-22   
Norethindrone Emzahh  2023-01-06   
Ethinyl estradiol, Norethindrone Oshih  2023-12-06   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
51%
18/35
Phase 2
48%
23/48
Phase 3
55%
18/33
Approved: 7Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Allergan
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use